Viking Therapeutics (NASDAQ: VKTX)
Viking Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Viking Therapeutics Company Info
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
News & Analysis
These 2 Biotech Stocks Are Set to Soar
Innovative drugmakers developing treatments for conditions with high unmet needs can produce lucrative wins.
Viking Therapeutics: A Bad Result for Roche's Weight-Management Pill Is Great News for Oral VK2735
Recently revealed trial results for Roche's experimental weight-management drug suggest Viking Therapeutics is on the right track.
Why Investors Plowed Into Viking Therapeutics Stock Today
The company is looking especially good after some bad news coming from a rival.
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
An investment in these players today could score a big win down the road.
Why Viking Therapeutics Stock Rocked the Market Today
The biotech continued to get attention from both pundits and investors, thanks largely to its investigational obesity drug.
Billionaires Are Buying Viking Therapeutics Stock Left and Right. Should You Follow Their Lead?
The huge demand for effective new weight management drugs has billionaire investors feeling bullish about this stock.
Prediction: This Biotech Stock Will Outperform Nvidia in the Second Half of the Year
Nvidia is heading for a 118% gain this year.
The Best Biotech Stock to Invest $1,000 in Right Now
This business has solid results in hand, lots of cash, and more catalysts coming.
Valuation
Earnings Transcripts
Viking Therapeutics (VKTX) Q2 2022 Earnings Call Transcript
VKTX earnings call for the period ending June 30, 2022.
Viking Therapeutics (VKTX) Q1 2022 Earnings Call Transcript
VKTX earnings call for the period ending March 31, 2022.
Viking Therapeutics (VKTX) Q4 2021 Earnings Call Transcript
VKTX earnings call for the period ending December 31, 2021.
Viking Therapeutics (VKTX) Q3 2021 Earnings Call Transcript
VKTX earnings call for the period ending September 30, 2021.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.